Last 162.10 INR
Change Today +3.10 / 1.95%
Volume 107.8K
As of 12:23 AM 02/28/15 All times are local (Market data is delayed by at least 15 minutes).

jubilant life sciences ltd (JOL) Snapshot

Open
161.50
Previous Close
159.00
Day High
168.00
Day Low
159.10
52 Week High
06/13/14 - 222.00
52 Week Low
12/17/14 - 115.60
Market Cap
25.8B
Average Volume 10 Days
712.3K
EPS TTM
6.85
Shares Outstanding
159.3M
EX-Date
08/21/14
P/E TM
23.7x
Dividend
3.00
Dividend Yield
1.86%
Current Stock Chart for JUBILANT LIFE SCIENCES LTD (JOL)

Related News

No related news articles were found.

jubilant life sciences ltd (JOL) Related Businessweek News

No Related Businessweek News Found

jubilant life sciences ltd (JOL) Details

Jubilant Life Sciences Limited, an integrated pharmaceutical and life sciences company, manufactures and supplies pharmaceutical and life sciences products and services worldwide. The company provides active pharmaceutical ingredients (APIs) for cardiovascular system (CVS) and central nervous system (CNS), as well as anti-infective and anti-ulcerants. Its APIs include solid dosage formulations for CVS, CNS, and anti-allergy categories; radiopharmaceuticals for the diagnosis, treatment, and monitoring of diseases; and allergy therapy products, including allergenic extracts and mixes, and skin test devices. The company also offers life sciences ingredients, such as pyridine and picoline; fine chemicals; crop science chemicals; nutrition products, including niacinamide, niacin (vitamin B3), and choline chloride; animal nutrition products in the category of vitamin and mineral premixes, betaine, acidifiers, toxin binders, growth promoters, and emulsifiers; acetyl products, which include acetic acid, monochloro acetic acid, acetic anhydride, ethyl acetate, and sodium mono chlor acetate; and specialty gases, such as liquid carbon dioxide and ethylene oxide mixtures. In addition, it provides contract manufacturing services in manufacturing sterile injectables, and solid and semi solid dosage forms; drug discovery services in bioinformatics, chemoinformatics, and crystallography structure directed molecular design and information technology; pre clinical services, such as medicinal chemistry, analytical chemistry, custom synthesis, library design, and clinical development and market launch services; and conducts integrated drug discovery and development programs on oncology, metabolic disorders, pain, and inflammation. The company was formerly known as Jubilant Organosys Limited and changed its name to Jubilant Life Sciences Limited in 2010. Jubilant Life Sciences Limited was incorporated in 1978 and is based in Noida, India.

6,100 Employees
Last Reported Date: 02/3/15
Founded in 1978

jubilant life sciences ltd (JOL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jubilant life sciences ltd (JOL) Key Developments

Jubilant Life Sciences Ltd Receives Abbreviated New Drug Application Final Approval from US FDA for Irbesartan Tablets USP, 75 mg, 150 mg, and 300 mg and Cetirizine Hydrochloride Tablets (Chewable), 5 mg and 10 mg

Jubilant Life Sciences Ltd. has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Irbesartan Tablets USP, 75 mg, 150 mg, and 300 mg, Cetirizine Hydrochloride Tablets (Chewable), 5 mg and 10 mg. Irbesartan Tablets USP, 75 mg, 150 mg, and 300 mg is the generic version of Avapro® (of Sanofi-Aventis), which is used for treating hypertension and nephropathy in type II diabetic patients. The total market size for Irbesartan Tablets as per IMS is approximately $50 million per annum. Cetirizine Hydrochloride Tablets (Chewable), 5 mg and 10 mg is the generic version of Zyrtec Chewable Tablets® (of Mcneil), used as an anti-histamine for the treatment of allergies.

Jubilant Life Sciences Limited Appoints Rajiv Shah as Company Secretary & Compliance Officer

Jubilant Life Sciences Limited announced that Mr. Rajiv Shah has been appointed as Company Secretary of the company with effect from February 16, 2015. He shall also be the Compliance officer of the Company.

Jubilant Life Sciences Ltd Announces Retirement of Lalit Jain as Company Secretary

Jubilant Life Sciences Ltd. announced that Mr. Lalit Jain has retired from the services of the company with effect from close of working hours of January 31, 2015. Mr. Lalit Jain is ceased to be the Company Secretary of the company with effect from close of working hours of January 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JOL:IN 162.10 INR +3.10

JOL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dishman Pharmaceuticals & Chemicals Ltd 153.65 INR -0.80
Glenmark Pharmaceuticals Ltd 777.35 INR -2.10
Piramal Enterprises Ltd 900.00 INR -6.35
Shasun Pharmaceuticals Ltd 269.40 INR -3.85
Torrent Pharmaceuticals Ltd 1,065 INR +21.90
View Industry Companies
 

Industry Analysis

JOL

Industry Average

Valuation JOL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 1.0x
Price/Cash Flow 9.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JUBILANT LIFE SCIENCES LTD, please visit www.jubl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.